Skip to main content
. 2015 Jan 22;6(14):11994–12008. doi: 10.18632/oncotarget.2740

Figure 6. Working model of the regulatory role of CRIPTO in regulating epithelial-mesenchymal transition in human prostate cancer cells.

Figure 6

Aberrant CR-1 expression can increase the activation of AKT and FGFR1, leading to deregulation of prostate epithelial differentiation towards a mesenchymal state that is coordinated by ZEB1, ZEB2 and TWIST1.